Latest information on
Skip to Content
Skip to Local Navigation
Skip to Global Navigation
Explore Stanford Medicine
Find a doctor
Pediatrician or pediatric specialist
Clinics & Services
Basic science departments
Clinical science departments
See full directory
Clinical research fellows
Continuing Medical Education
Residencies & fellowships
High School & Undergraduate Programs
Basic science departments
Clinical science departments
Support teaching, research, and patient care.
Ways to give
Why giving matters
Make a gift online
Maps & directions
How you can help
Submit Search Query
Clinical Assistant Professor, Medicine - Hematology
Clinical Assistant Professor,
Medicine - Hematology
Program director, Hematology Fellowship (2017 - Present)
Fellowship: Stanford University Hematology and Oncology Fellowship (2013) CA
Residency: Stanford University Internal Medicine Residency (2009) CA
Board Certification: American Board of Internal Medicine, Hematology (2012)
Medical Education: SUNY Downstate College of Medicine (2006) NY
269 Campus Dr Rm 1145A
Stanford CA 94305
Tel: (650) 723-6661
Fax: (650) 849-0505
VA Palo Alto Health Care System Dept of Hematology
3801 Miranda Ave
Palo Alto CA 94304
Fax: (650) 849-1213
Profiles With Related Publications
Saul A. Rosenberg, MD, Professor of Lymphoma
Cancer > Lymphoma, Burkitt's Lymphoma, Hodgkin's Disease, Investigational Therapeutics, Lymphoma , Mycosis Fungoides, Non-Hodgkin's Lymphoma, Oncology (Cancer), Plasmacytoma, Waldenstrom's Macroglobulinemia , Medical Oncology
Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies.
The research program is highly collaborative with radiation oncology, industry, pathology and dermatology.
Associate Professor of Pediatrics (Stem Cell Transplantation)
Blood and Marrow Transplantation, Pediatric, Pediatric Hematology-Oncology, Cell and Gene therapy
Hematopoietic Stem cell biology-created a SCID mouse model to study engraftment of cord blood derived hematopoietic cells and use of this model to develop gene transfer technology for Fanconi anemia.
Clinical research interests are to develop new protocols to reduce graft vs host disease,treatment of viral infections post transplant and use of manipulated HSC graft in patients who receive mismatched donor transplants.
Ash A. Alizadeh, MD/PhD
Moghadam Family Professor
Cancer > Lymphoma, Lymphoma, B-Cell Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Burkitt Lymphoma, Follicular Lymphoma, Diffuse Large-Cell Lymphomas, Leukemia, Hairy Cell, Lymphoma, B-Cell, Marginal Zone, Hodgkin Disease, Medical Oncology
My research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.
Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials.
Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital, Emeritus
Bone marrow transplantation (BMT) is a treatment modality which is being broadly applied to a growing number of disorders. Increasing success with BMT is offering improved survival to pediatric and adult patients with acute leukemia, chronic leukemia, lymphomas, and a variety of solid tumors as well as severe aplastic anemia.
Elizabeth Bailey, MD, MPH
Clinical Associate Professor, Dermatology
Dermatology, Skin cancer detection and prevention, Adult general dermatology, Dermatopathology
Brian T. Bateman
Anesthesiology, Perioperative and Pain Medicine Professor
Clinical Associate Professor, Medicine - Hematology
Cancer > Hematology, Hemostasis Thrombosis, Anticoagulation, Hematology, Idiopathic thrombocytopenic purpura, Pregnancy-related hematologic conditions, Anemia, Leukemia - Hematology
A. Dimitrios Colevas
Professor of Medicine (Oncology) and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Radiation Oncology (Radiation Therapy)
Cancer > Head and Neck Cancer, Oncology (Cancer), developmental therapeutics, investigational new drugs, Adverse event( toxicity) evaluation and reporting, Thyroid Cancer, combined chemotherapy and radiation treatment, Medical Oncology
Multi- modality treatment of Head and Neck Cancer
Phase 1 clinical trials
Professor of Medicine (Hematology)
Cancer > Hematology, Cancer > Hematology > Leukemia - Acute and Chronic, Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemias, Plasmacytoma, Idiopathic Hypereosinophillic Syndrome, Hematology
My research integrates clinical care of patients with novel treatments for a variety of hematologic disorders. I see patients with a wide range of problems with a particular focus on chronic lymphocytic leukemia and multiple myeloma. I provide comprehensive consultative services as well as treatment for both the acute and chronic leukemias as well as non-malignant conditions such as clotting disorders and thrombocytopenia.
Professor of Pediatrics (Hematology/Oncology)
Pediatric Hematology-Oncology, Ped Hematology/Oncology
Hematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins.
Clinical Assistant Professor, Radiology - Pediatric Radiology
Assistant Professor of Pediatrics (Hematology/Oncology)
Childhood cancers can be considered aberrations of normal tissue development. We are interested in understanding childhood cancers through the lens of normal development. Further, individual tumors are composed of heterogeneous cell populations, not all cells being equal in their ability to respond to treatment or to repopulate a tumor. Thus, we take single cell approach to determine populations of clinical relevance.
Publication Topics For This Person
Antineoplastic Combined Chemotherapy Protocols
Precursor Cell Lymphoblastic Leukemia-Lymphoma